Review highlights next-generation cancer therapies targeting PIK3CA mutations

[News]

A newly published review in Genes & Diseases explores the oncogenic activation of PIK3CA in cancer and highlights emerging targeted therapies designed to improve treatment efficacy while reducing side effects.

More... (https://www.news-medical.net/news/20250225/Review-highlights-next-generation-cancer-therapies-targeting-PIK3CA-mutations.aspx)